UBS Group’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
VCM
VPM
OAG
GIM
UBS Group's STE Position: Q1 2026 in Review
UBS Group increased its Steris (STE) stake by 6.7% in Q1 2026, buying an estimated $8.39M and bringing the position to 546,856 shares worth $121M. The position accounts for 0.02% of the portfolio, ranked #920.
UBS Group first reported a position in STE in Q4 2014 and has held it in 46 quarters since. The position peaked at $130M in Q4 2025. 840 funds tracked by Wall St. Rank hold STE as of Q1 2026.
- UBS Group held 546,856 shares of Steris worth $121M as of Q1 2026.
- UBS Group bought 34,283 Steris shares in Q1 2026, an estimated $8.39M.
- Steris made up 0.02% of UBS Group's portfolio in Q1 2026, its #920 holding.
- UBS Group first reported a position in Steris in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Steris position peaked at $130M in Q4 2025.
- 840 funds tracked by Wall St. Rank held Steris as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.